Fluorescein angiography versus optical coherence tomography-guided planning for macular laser photocoagulation in diabetic macular edema

Retina

Volumn 34, Issue 8, 2014, Pages 1600-1605

  Kozak, Igor ^a   El Emam, Sharif Y ^b   Cheng, Lingyun ^b   Bartsch, Dirk Uwe ^b   Chhablani, Jay ^c   Freeman, William R ^b   Arevalo, J Fernando ^a,d  

^a KING KHALED EYE SPECIALIST HOSPITAL   (Saudi Arabia)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c L V PRASAD EYE INSTITUTE   (India)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Diabetic macular edema; Fluorescein angiography; Laser photocoagulation; Optical coherence tomography

Indexed keywords

ADULT; ARTICLE; CENTRAL RETINAL THICKNESS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INTERMETHOD COMPARISON; LASER; LASER COAGULATION; MALE; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PHOTOCOAGULATOR; RANDOMIZED CONTROLLED TRIAL; TREATMENT PLANNING; COMPARATIVE STUDY; COMPUTER ASSISTED SURGERY; DIABETIC RETINOPATHY; DOUBLE BLIND PROCEDURE; MACULAR EDEMA; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; RETINA MACULA LUTEA; VISUAL ACUITY;

DIABETIC RETINOPATHY; DOUBLE-BLIND METHOD; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; LASER COAGULATION; MACULA LUTEA; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURGERY, COMPUTER-ASSISTED; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 84905123378     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000120     Document Type: Article

References (20)

1. Bhagat N, Grigorian RA, Tutela A, Zarbin MA. Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol 2009; 54: 1-32.
2. Massin P, Bandello F, Garweg JG, et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care 2010; 33: 2399-2405.
3. Nguyen QD, Brown DM, Marcus DM, et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 2012; 119: 789-801.
4. Nguyen QD, Shah SM, Khwaja AA, et al. Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology 2010; 117: 2146-2151.
5. Mitchell P, Bandello F, Schmidt-Erfurth U, et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 2011; 118: 615-625.
6. Elman MJ, Bressler NM, Qin H, et al. Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2011; 118: 609-614.
7. Smiddy WE. Clinical applications of cost analysis of diabetic macular edema treatments. Ophthalmology 2012; 119: 2558-2562.
8. Kozak I, Oster SF, Cortes MA, et al. Clinical evaluation and treatment accuracy in diabetic macular edema using navigated laser photocoagulator NAVILAS. Ophthalmology 2011; 118: 1119-1124.
9. Neubauer AS, Langer J, Liegl R, et al. Navigated macular laser decreases retreatment rate for diabetic macular edema: a comparison with conventional macular laser. Clin Ophthalmol 2013; 7: 121-128.
10. Brown JC, Solomon SD, Bressler SB, et al. Detection of diabetic foveal edema: contact lens biomicroscopy compared with optical coherence tomography. Arch Ophthalmol 2004; 122: 330-335.
11. Browning DJ, McOwen MD, Bowen RM Jr, O'Marah TL. Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography. Ophthalmology 2004; 111: 712-715.
12. Davis MD, Bressler SB, Aiello LP, et al. Diabetic Retinopathy Clinical Research Network Study Group. Comparison of timedomain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema. Invest Ophthalmol Vis Sci 2008; 49: 1745-1752.
13. Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Ophthalmology 1987; 94: 761-774.
14. Kylstra JA, Brown JC, Jaffe GJ, et al. The importance of fluorescein angiography in planning laser treatment of diabetic macular edema. Ophthalmology 1999; 106: 2068-2073.
15. Vemala R, Koshy S, Sivaprasad S. Qualitative and quantitative OCT response of diffuse diabetic macular oedema to macular laser photocoagulation. Eye (Lond) 2011; 25: 901-908.
16. Gallego-Pinazo R, Suelves-Cogollos AM, Dolz-Marco R, et al. Macular laser photocoagulation guided by spectral-domain optical coherence tomography versus fluorescein angiography for diabetic macular edema. Clin Ophthalmol 2011; 5: 613-617.
17. Kozak I, Morrison VL, Clark TM, et al. Discrepancy between fluorescein angiography and optical coherence tomography in detection of macular disease. Retina 2008; 28: 538-544.
18. Ossewaarde-van Norel J, Camfferman LP, Rothova A. Discrepancies between fluorescein angiography and optical coherence tomography in macular edema in uveitis. Am J Ophthalmol 2012; 154: 233-239.
19. Byeon SH, Chu YK, Hong YT, et al. New insights into the pathoanatomy of diabetic macular edema: angiographic patterns and optical coherence tomography. Retina 2012; 32: 1087-1099.
20. van Dijk HW, Verbraak FD, Kok PH, et al. Variability in photocoagulation treatment of diabetic macular oedema. Acta Ophthalmol 2013; 91: 722-727.